Search Result |
Top |
Entry | Name | Description | Category | Pathway | Gene |
---|---|---|---|---|---|
H00070 | Galactosemia | Galactosemia (GALAC) is an autosomal recessive disorder caused by a defect in one of the enzyme genes for galactose metabolism. Newborns with the enzyme deficiency cannot properly metabolize milk sugar ... | Inherited metabolic disorder |
(GALAC1) GALT [HSA:2592] [KO:K00965] (GALAC2) GALK1 [HSA:2584] [KO:K00849] (GALAC3) GALE [HSA:2582] [KO:K01784] (GALAC4) GALM [HSA:130589] [KO:K01785] |
|
H00875 | Megaloencephalic leukoencephalopathy with subcortical cysts | ... [DS:H00065], Canavan disease [DS:H00074], glutaric acidemia type I [DS:H00178]) that present in infancy with megalencephaly. An autosomal recessive mutations in the MLC1 gene have been shown to cause this condition ... | Nervous system disease |
(MLC1) MLC1 [HSA:23209] [KO:K20070] (MLC2A/2B) HEPACAM [HSA:220296] [KO:K23116] (MLC3) GPRC5B [HSA:51704] [KO:K04619] (MLC4) AQP4 [HSA:361] [KO:K09866] |
|
H00878 | Cystic leukoencephalopathy without megalencephaly | Cystic leukoencephalopathy without megalencephaly is an autosomal recessive infantile-onset neurological disorder. The affected individuals are asymptomatic at birth and show a static encephalopathy with ... | Inherited metabolic disorder | RNASET2 [HSA:8635] [KO:K01166] | |
H00978 | Thrombocytopenia (THC) | Thrombocytopenia is defined by a decrease in the number of platelets in circulating blood, resulting in the potential for increased bleeding and decreased ability for clotting. Inherited syndromes are ... | Hematologic disease |
(THC1) WAS [HSA:7454] [KO:K05747] (THC2) ANKRD26 [HSA:22852] [KO:K25138] (THC3) FYB1 [HSA:2533] [KO:K17698] (THC4) CYCS [HSA:54205] [KO:K08738] (THC5) ETV6 [HSA:2120] [KO:K03211] (THC6) SRC [HSA:6714] [KO:K05704] (THC7) IKZF5 [HSA:64376] [KO:K09220] (THC8) ACTB [HSA:60] [KO:K05692] (THC9) THPO [HSA:7066] [KO:K06854] (THC10) PTPRJ [HSA:5795] [KO:K05698] (THC11) RAP1B [HSA:5908] [KO:K07836] (THC12) GNE [HSA:10020] [KO:K12409] (THC13) GALE [HSA:2582] [KO:K01784] (XLTT/XLTDA) GATA1 [HSA:2623] [KO:K09182] (THAMY) MPIG6B [HSA:80739] [KO:K25640] (FPDMM) RUNX1 [HSA:861] [KO:K08367] |
|
H01112 |
Polyhydramnios, megalencephaly, and symptomatic epilepsy PMSE syndrome |
Polyhydramnios, megalencephaly, symptomatic epilepsy (PMSE) is a severe human developmental and epileptic syndrome caused by a homozygous partial deletion in the STRAD-alpha gene (LYK5), truncating 180 ... | Congenital malformation | STRADA [HSA:92335] [KO:K08271] | |
H01833 | Hemimegalencephaly | Hemimegalencephaly is a rare brain malformation caused by anomalous neuronal and glial proliferation or differentiation, with an abnormally enlarged and dysplastic hemisphere. It can occur as an isolated ... | Congenital malformation | ||
H01885 |
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome MPPH syndrome |
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome (MPPH) is rare overgrowth disorder. MCAP [DS:H02153] and MPPH show very similar symptoms; the main symptoms are progressive megalencephaly ... | Congenital malformation |
(MPPH1) PIK3R2 [HSA:5296] [KO:K02649] (MPPH2) AKT3 [HSA:10000] [KO:K04456] (MPPH3) CCND2 [HSA:894] [KO:K10151] |
|
H01928 |
Smith-Kingsmore syndrome Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome |
... underlie SKS. The most consistent findings in SKS are intellectual disability (ID), developmental delay, megalencephaly, and seizures. There is moderate clinical variability, ranging from patients with macrocephaly ... | Congenital malformation | MTOR [HSA:2475] [KO:K07203] | |
H02010 |
Galactose epimerase deficiency Galactosemia III |
Galactose epimerase deficiency is the least understood form of galactosemia. Originally, galactose epimerase deficiency was identified as a biochemical oddity that impacted only red and white blood cells ... | Inherited metabolic disorder | GALE [HSA:2582] [KO:K01784] | |
H02153 |
Megalencephaly-capillary malformation syndrome MCAP syndrome |
Megalencephaly-capillary malformation (MCAP) syndrome is a rare overgrowth syndrome. The main symptoms are progressive megalencephaly, polymicrogyria, capillary malformations, syndactyly, and connective ... | Congenital malformation | PIK3CA [HSA:5290] [KO:K00922] | |
H02446 | Autosomal recessive macrocephaly/megalencephaly syndrome | Autosomal recessive macrocephaly/megalencephaly syndrome (MGCPH) is characterized by intellectual disability, macro crania, and megalencephaly. Mutations in TBC1D7 were reported in patients. TBC1D7 forms ... | Congenital malformation | TBC1D7 [HSA:51256] [KO:K20396] |
[ KEGG | DISEASE | DRUG | MEDICUS ] |